-
Getting the balance right in African healthcare
Although many African countries' increased focus on strengthening their healthcare systems has led to significant gains in terms of improving health outcomes, the continent continues to struggle with huge challenges such as underfunding, dire shortages of healthcare professionals and a growing double disease burden that encompasses both communicable diseases (CDs) and non-communicable diseases (NCDs).
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- public health
-
Ambitious Chan Zuckerberg Initiative to combat disease is about to be tested
Facebook CEO Mark Zuckerberg’s ambitious $3bn aim to “cure, prevent and manage” all disease in one generation is about to take shape in a $600m “Biohub” in Silicon Valley.
- Categories
- Health Care
- Region
- North America
-
Indian Tech Entrepreneur on Mission to Democratise Healthcare
A leading Indian tech entrepreneur has decided to invest in a UK-based genomics data platform company to “democratise precision healthcare” and help pharmaceuticals develop targeted therapeutics. Ambarish Mitra, well known as the co-founder and CEO of Blippar – an augmented reality and computer vision based AI application platform – will invest in the Cambridge-based Global Gene Corp to bring medicine to the masses. “Global Gene Corp sits at the convergence point of genomic & life sciences, machine learning and big data technologies. They have fundamentally disrupted the business model to deliver a platform that is scalable and affordable – which is key to bringing precision medicine to the masses,” Mitra said.
- Categories
- Health Care
- Region
- South Asia
-
Getting the balance right in African healthcare
Although many African countries' increased focus on strengthening their healthcare systems has led to significant gains in terms of improving health outcomes, the continent continues to struggle with huge challenges such as underfunding, dire shortages of healthcare professionals and a growing double disease burden that encompasses both communicable diseases (CDs) and non-communicable diseases (NCDs).
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Ambitious Chan Zuckerberg Initiative to combat disease is about to be tested
Facebook CEO Mark Zuckerberg’s ambitious $3bn aim to “cure, prevent and manage” all disease in one generation is about to take shape in a $600m “Biohub” in Silicon Valley.
- Categories
- Health Care
-
Indian tech entrepreneur on mission to democratise healthcare
A leading Indian tech entrepreneur has decided to invest in a UK-based genomics data platform company to “democratise precision healthcare” and help pharmaceuticals develop targeted therapeutics.
- Categories
- Health Care
- Region
- South Asia
-
Social Business Roundup: Laureate Education Goes Big, Omidyar Gives Directly, Surdna Foundation Embraces Impact Investing
In social business news this week, the world's biggest for-profit college company raised $490 million in its public debut, Omidyar Network gave a $493,000 grant to support GiveDirectly's mission of sending unconditional cash transfers to the poor, and the Surdna Foundation announced plans to dedicate 10 percent of its endowment ($100 million) to a new impact investing fund. Read about these developments and more in our news roundup.
- Categories
- Education, Health Care, Investing, Social Enterprise
-
Global Health Leaders Seek New Ties to Tech Industry, While Aiming to Avoid ‘Innovation Addiction’
It’s easy to see global health as a far-off issue, one that doesn’t have much impact outside isolated parts of the world. But at a symposium on global health today at the University of Washington, leaders in the field argued just the opposite.
- Categories
- Health Care, Technology
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.